Daniel Gero1, Lucie Favre2, Pierre Allemann1, Pierre Fournier1, Nicolas Demartines1, Michel Suter3,4,5. 1. Department of Visceral Surgery, University Hospital (CHUV), Lausanne, Switzerland. 2. Division of Endocrinology, Diabetology and Metabolism, University Hospital (CHUV), Lausanne, Switzerland. 3. Department of Visceral Surgery, University Hospital (CHUV), Lausanne, Switzerland. michelsuter@netplus.ch. 4. Department of Surgery, Riviera-Chablais Hospital, Aigle-Monthey, Switzerland. michelsuter@netplus.ch. 5. Hopital Riviera-Chablais, Chemin du Grand-Chêne, 1860, Aigle, Switzerland. michelsuter@netplus.ch.
Abstract
BACKGROUND: Dyslipidemia is a known risk factor for cardiovascular (CV) events. The aim of the study was to assess lipid profiles and their impact on CV risk changes in a large patient cohort 5 years after Roux-en-Y gastric bypass (RYGB). METHODS: All patients who underwent primary RYGB for severe obesity in our two hospitals between January 1999 and December 2009 were included. The Framingham risk score was used. RESULTS: One thousand and forty-eight patients were included, 791 women and 257 men. Five-year complete lipid profile was available for 77% of patients. At 5 years, mean body mass index (BMI) decreased from 45.7 ± 6 to 31 ± 5.8 kg/m2 (p < 0.001), excess BMI loss (EBMIL) was 72.35 ± 22%, and total body weight loss (TWL) 31.5 ± 9%. Lipid values improved significantly. Total- and LDL-cholesterol levels dropped at 1 year from 5.4 to 4.48 mmol/L and 3.2 to 2.41 mmol/L, respectively, and slightly increased thereafter. Triglyceride levels dropped from 2 to 1.17 mmol/L at 1 year and remained unchanged. HDL levels rose continuously from 1.27 to 1.77 mmol/L at 5 years. Lipid profile improved more in patients with greater weight loss (%EBMIL ≥ 50 or %TWL ≥ 25%). Assuming that all patients were non-smokers and other baseline risk factors (hypertension, diabetes) remained unchanged at 5 years, the amelioration of the lipid profile itself yielded to a 27% reduction of CV risk (p < 0.001). CONCLUSIONS: RYGB results in sustained excess weight loss and in amelioration of the lipid profile from the first to fifth postoperative year. This improvement translates into significantly lower CV risk from the first year after surgery.
BACKGROUND:Dyslipidemia is a known risk factor for cardiovascular (CV) events. The aim of the study was to assess lipid profiles and their impact on CV risk changes in a large patient cohort 5 years after Roux-en-Y gastric bypass (RYGB). METHODS: All patients who underwent primary RYGB for severe obesity in our two hospitals between January 1999 and December 2009 were included. The Framingham risk score was used. RESULTS: One thousand and forty-eight patients were included, 791 women and 257 men. Five-year complete lipid profile was available for 77% of patients. At 5 years, mean body mass index (BMI) decreased from 45.7 ± 6 to 31 ± 5.8 kg/m2 (p < 0.001), excess BMI loss (EBMIL) was 72.35 ± 22%, and total body weight loss (TWL) 31.5 ± 9%. Lipid values improved significantly. Total- and LDL-cholesterol levels dropped at 1 year from 5.4 to 4.48 mmol/L and 3.2 to 2.41 mmol/L, respectively, and slightly increased thereafter. Triglyceride levels dropped from 2 to 1.17 mmol/L at 1 year and remained unchanged. HDL levels rose continuously from 1.27 to 1.77 mmol/L at 5 years. Lipid profile improved more in patients with greater weight loss (%EBMIL ≥ 50 or %TWL ≥ 25%). Assuming that all patients were non-smokers and other baseline risk factors (hypertension, diabetes) remained unchanged at 5 years, the amelioration of the lipid profile itself yielded to a 27% reduction of CV risk (p < 0.001). CONCLUSIONS: RYGB results in sustained excess weight loss and in amelioration of the lipid profile from the first to fifth postoperative year. This improvement translates into significantly lower CV risk from the first year after surgery.
Authors: J Hunter Mehaffey; Damien J LaPar; Kathleen C Clement; Florence E Turrentine; Michael S Miller; Peter T Hallowell; Bruce D Schirmer Journal: Ann Surg Date: 2016-07 Impact factor: 12.969
Authors: Aditya D Hendrani; Tolulope Adesiyun; Renato Quispe; Steven R Jones; Neil J Stone; Roger S Blumenthal; Seth S Martin Journal: World J Cardiol Date: 2016-02-26
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2014-03-31 Impact factor: 91.245
Authors: Sean P Heffron; Amar Parikh; Alexandar Volodarskiy; Christine Ren-Fielding; Arthur Schwartzbard; Joseph Nicholson; Sripal Bangalore Journal: Am J Med Date: 2016-02-18 Impact factor: 4.965
Authors: Jussi Pihlajamäki; Sari Grönlund; Marko Simonen; Pirjo Käkelä; Leena Moilanen; Matti Pääkkönen; Elina Pirinen; Marjukka Kolehmainen; Vesa Kärjä; Sakari Kainulainen; Matti Uusitupa; Esko Alhava; Tatu A Miettinen; Helena Gylling Journal: Metabolism Date: 2009-12-16 Impact factor: 8.694
Authors: Alberto Goday; David Benaiges; Alejandra Parri; José M Ramón; Juana A Flores-Le Roux; Juan Pedro Botet Journal: Surg Obes Relat Dis Date: 2014-05-02 Impact factor: 4.734
Authors: Styliani Mantziari; Anna Dayer; Céline Duvoisin; Nicolas Demartines; Pierre Allemann; Jean-Marie Calmes; Lucie Favre; Pierre Fournier; Michel Suter Journal: Obes Surg Date: 2020-04 Impact factor: 4.129
Authors: Larissa Monteiro Costa Pereira; Felipe J Aidar; Dihogo Gama de Matos; Jader Pereira de Farias Neto; Raphael Fabrício de Souza; Antônio Carlos Sobral Sousa; Rebeca Rocha de Almeida; Marco Antonio Prado Nunes; Albená Nunes-Silva; Walderi Monteiro da Silva Júnior Journal: Int J Environ Res Public Health Date: 2019-06-04 Impact factor: 3.390
Authors: Ezequiel Lozano Chiappe; Maximiliano Martin; Andrea Iglesias Molli; Andrea Millan; Walter Tetzlaff; Eliana Botta; Florencia Ferraro; Maria S Sáez; Maria V Lorenzon Gonzalez; Laura Boero; Patricia Sorroche; Axel Beskow; Mercedes Gutierrez; Gloria Cerrone; Susana Gutt; Gustavo Frechtel; Fernando Brites Journal: Obes Surg Date: 2020-10-30 Impact factor: 4.129